Results 261 to 270 of about 205,027 (361)

Immunoglobulin G Fc engineering for localized therapy: Eliminating neonatal Fc receptor interactions and ensuring purification using protein A

open access: yesProtein Science, Volume 34, Issue 11, November 2025.
Abstract Monoclonal antibodies (mAbs) and bispecific antibodies (bsAbs) have transformed therapeutic strategies for various diseases. However, administering them can lead to unwanted adverse effects and insufficient delivery to local disease sites.
Akifumi Kato   +7 more
wiley   +1 more source

Japanese clinical guidelines for neovascular age-related macular degeneration. [PDF]

open access: yesJpn J Ophthalmol
Iida T   +7 more
europepmc   +1 more source

Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

open access: yesActa Ophthalmologica, Volume 103, Issue 7, Page e436-e455, November 2025.
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs   +12 more
wiley   +1 more source

Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration [PDF]

open access: hybrid, 2003
Xiaorong Gu   +6 more
openalex   +1 more source

Preservatives in artificial tears: Assessing impact on dry eye symptoms

open access: yesActa Ophthalmologica, Volume 103, Issue 7, Page 823-830, November 2025.
Abstract Purpose To examine the association between the presence of dry eye disease (DED) symptoms when using BAK‐preserved artificial tears (AT) compared to preservative‐free AT. Methods In this cross‐sectional study, we used data collected as part of Project ‘Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive ...
Astrid Dissing Sjö   +3 more
wiley   +1 more source

Efdamrofusp alfa: an insight into the novel drug and its use in age-related macular degeneration. [PDF]

open access: yesInt J Retina Vitreous
Rath S   +7 more
europepmc   +1 more source

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis

open access: yesActa Ophthalmologica, Volume 103, Issue 7, Page 741-763, November 2025.
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler   +17 more
wiley   +1 more source

Age-related macular degeneration associated with optic disc drusen. [PDF]

open access: yesFront Ophthalmol (Lausanne)
Alkhabaz A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy